# CLEARSIDE BIOMEDICAL INC (CLSD)

> Institutional ownership reported to the SEC as of Q3 2025, from Form 13F filings. Source: https://holderbook.com/stocks/CLSD/

- Reporting holders: 3
- Reported value: $446.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Carmignac Gestion](https://holderbook.com/funds/1569758-carmignac-gestion/) | $399.2K | 100,556 | 0.0% | 23 |
| [Apollon Wealth Management, LLC](https://holderbook.com/funds/1764387-apollon-wealth-management-llc/) | $46.8K | 11,793 | 0.0% | 1 |
| [OSAIC HOLDINGS, INC.](https://holderbook.com/funds/1677044-osaic-holdings-inc/) | $900 | 2,500 | 0.0% | 23 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2025 | 3 | $446.9K |
| Q2 2025 | 44 | $7.5M |
| Q1 2025 | 45 | $8.2M |
| Q4 2024 | 45 | $9.0M |
| Q3 2024 | 48 | $12.9M |
| Q2 2024 | 49 | $17.9M |
| Q1 2024 | 53 | $24.3M |
| Q4 2023 | 46 | $9.3M |
| Q3 2023 | 46 | $6.9M |
| Q2 2023 | 53 | $9.8M |
| Q1 2023 | 49 | $9.3M |
| Q4 2022 | 53 | $10.3M |